Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 20,000 shares at $96.38 ($1.9M) on 2024-01-10, disclosed to the SEC on 2024-01-11.
Scheduled sale ($1.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.19 | 10,000 | $982K | 50.5% |
| 2 | $96.38 | 10,000 | $964K | 49.5% |
| Total | $97.28 avg | 20,000 | $1.9M | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |